Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT

被引:24
|
作者
Sekine, Tetsuro [1 ,2 ]
Barbosa, Felipe de Galiza [1 ]
Delso, Gaspar [1 ,3 ]
Burger, Irene A. [1 ]
Stolzmann, Paul [1 ]
ter Voert, Edwin E. [1 ]
Huber, Gerhard F. [4 ]
Kollias, Spyros S. [5 ]
von Schulthess, Gustav K. [1 ]
Veit-Haibach, Patrick [1 ,6 ]
Huellner, Martin W. [1 ]
机构
[1] Univ Zurich, Dept Nucl Med, Univ Zurich Hosp, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Nippon Med Sch, Dept Radiol, Tokyo, Japan
[3] GE Healthcare, Waukesha, WI USA
[4] Univ Zurich, Dept Otorhinolaryngol & Head & Neck Surg, Univ Zurich Hosp, Zurich, Switzerland
[5] Univ Zurich, Clin Neuroradiol, Univ Zurich Hosp, Zurich, Switzerland
[6] Univ Zurich, Inst Diagnost & Intervent Radiol, Univ Zurich Hosp, Zurich, Switzerland
关键词
ear; nose; and throat (ENT) surgery; head and neck cancer; multimodality imaging; oncology; positron emission tomography (PET)/MRI; positron emission tomography (PET)/CT; PERINEURAL SPREAD; FOLLOW-UP; PET/MR; TUMORS; F-18-FDG-PET/CT; PERFORMANCE; CARCINOMA; LARYNGEAL; INVASION; IMPACT;
D O I
10.1002/hed.24783
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: The purpose of this study was to compare the diagnostic accuracy of positron emission tomography (PET)/MRI with PET/CT for local resectability of head and neck cancer. Methods: Sequential contrast-enhanced PET/CT-MRI was performed in 58 patients referred for the staging or restaging of head and neck cancer. Tumors were assessed with PET/CT and PET/MRI for the presence of resectability-defining factors: T4b status (mediastinal invasion, invasion of the prevertebral space, and vascular encasement), and another 8 findings that would imply obstacles for surgical cure (invasion of the laryngeal cartilage, invasion of the preepiglottic fat pad, perineural spread, orbital invasion, bone infiltration, skull base invasion, dural infiltration, and invasion of the brachial plexus). Results: The sensitivity/specificity/accuracy of local resectability-defining factors of PET/CT and PET/MRI was 0.92/0.99/0.98 and 0.98/0.99/0.99 (P = .727), respectively, per lesion, and 0.96/0.87/0.91 and 0.96/0.90/0.93 (P = .687), respectively, per patient. Conclusion: Both contrast-enhanced PET/MRI and contrast-enhanced PET/CT can serve as reliable examinations for defining local resectability of head and neck cancer.
引用
收藏
页码:1550 / 1558
页数:9
相关论文
共 50 条
  • [31] Positron emission tomography in the evaluation of stage III and IV head and neck cancer
    Teknos, TN
    Rosenthal, EL
    Lee, D
    Taylor, R
    Marn, CS
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (12): : 1056 - 1060
  • [32] Positron emission tomography for radiotherapy planning in head and neck cancer: What impact?
    Flaus, Anthime
    Nevesny, Stephane
    Guy, Jean-Baptiste
    Sotton, Sandrine
    Magne, Nicolas
    Prevot, Nathalie
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (03) : 234 - 243
  • [33] Uses and limitations of FDG positron emission tomography in patients with head and neck cancer
    Hanasono, MM
    Kunda, LD
    Segall, GM
    Ku, GH
    Terris, DJ
    LARYNGOSCOPE, 1999, 109 (06): : 880 - 885
  • [34] The utility of positron emission tomography (PET) scanning in the workup of head and neck cancer
    Robnett, TJ
    Mozley, PD
    Alavi, A
    Weber, RS
    Weinstein, GS
    Machtay, M
    RADIOLOGY, 2000, 217 : 211 - 211
  • [35] The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy
    Sherriff, J. M.
    Ogunremi, B.
    Colley, S.
    Sanghera, P.
    Hartley, A.
    BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1019): : E1120 - E1126
  • [36] Positron emission tomography and computed tomography (PET/CT) in lung cancer
    Altamirano-Ley, Javier
    Estrada-Sanchez, Gisela
    Javier Ochoa-Carrillo, Francisco
    CIRUGIA Y CIRUJANOS, 2007, 75 (04): : 297 - 304
  • [37] A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
    Pennant, M.
    Takwoingi, Y.
    Pennant, L.
    Davenport, C.
    Fry-Smith, A.
    Eisinga, A.
    Andronis, L.
    Arvanitis, T.
    Deeks, J.
    Hyde, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (50) : 1 - +
  • [38] An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
    Auguste, P.
    Barton, P.
    Hyde, C.
    Roberts, T. E.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (18) : 1 - +
  • [39] Positron emission tomography-CT surveillance versus neck dissection in advanced head and neck cancer: time for a paradigm shift in management
    Kass, Jason I.
    Mehta, Vikas
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S203 - S204
  • [40] Cost-Effectiveness of Positron Emission Tomography/Computed Tomography in the Management of Advanced Head and Neck Cancer
    Kurien, George
    Hu, Jia
    Harris, Jeffrey
    Seikaly, Hadi
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2011, 40 (06): : 468 - 472